# Older Adults Turn to Cannabis Primarily for Symptom Management – Pulmonology Advisor > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/older-adults-turn-to-cannabis-primarily-for-symptom-management-pulmonology-advisor/ > **Published:** 2026-05-29T22:21:37-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:53:49-04:00 > **Clinical Summary:** Why older adults use cannabis symptom management, safety considerations, and clinical approach to informed shared decision-making in geriatric care. --- ✦ New CED Clinical Relevance #78 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. AgingPainSleepResearchSafetyCBDTHC Why This Matters Clinicians treating older adults need to understand that many patients are self-selecting cannabis for symptom management, often viewing it as an alternative to traditional pharmaceuticals, which requires direct discussion to assess efficacy, [drug interactions](https://cedclinic.com/cannabis-liver-interactions-study-insights/), and safety risks in this vulnerable population. The lack of robust clinical evidence in older adults means physicians must develop informed counseling strategies to guide patients toward evidence-based approaches while acknowledging patient preferences and symptoms driving [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/). Integrating [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) history into standard clinical assessment allows providers to better manage polypharmacy concerns and tailor treatment plans that address the underlying conditions older patients are attempting to treat. Clinical Summary Older adults increasingly use cannabis for symptom management, particularly as an alternative or adjunct to conventional pharmacotherapy, reflecting a significant shift in medication-seeking behavior within this population. This trend underscores the need for geriatric practitioners to routinely assess [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) during clinical encounters, as older patients may not spontaneously disclose use due to stigma or assumptions about physician disapproval. The preference for cannabis as a perceived safer or more natural option among seniors raises important clinical concerns regarding [drug interactions](https://cedclinic.com/cannabis-liver-interactions-study-insights/) with polypharmacy, fall risk, cognitive effects, and the lack of robust efficacy and safety data in this age group. Clinicians should engage in non-judgmental discussions about cannabis use to understand patient motivations, educate patients about evidence gaps and potential risks, and ensure informed decision-making aligned with their medical conditions and existing medications. For patients considering cannabis, physicians should emphasize the need for rigorous clinical evidence, encourage trial of evidence-based alternatives first, and monitor for adverse effects if use is ongoing. Healthcare providers should advocate for more targeted research on [cannabis safety](https://cedclinic.com/respiratory-effects-inhalational-marijuana/) and efficacy in older adults to guide practice and protect this vulnerable population from potential harm. Dr. Caplan’s Take “What I’m seeing in my practice is that older patients aren’t chasing a high; they’re looking for relief from [chronic pain](https://cedclinic.com/cannabinoids-pain-management-opioid-alternative/), sleep disruption, and nausea where conventional medications have either failed or created intolerable [side effects](https://cedclinic.com/cannabis-intoxication-memory-disruption/), and until we have rigorous clinical data on dosing and [drug interactions](https://cedclinic.com/cannabis-liver-interactions-study-insights/) in this population, we’re essentially flying blind while our patients self-titrate in the shadows.” Clinical Perspective As cannabis use among older adults continues to rise, clinicians should recognize that most patients in this population report using it for symptom management rather than recreational purposes, often viewing it as a potentially safer alternative to conventional medications. However, this perception warrants careful clinical scrutiny, as evidence for efficacy in older adults remains limited compared to younger populations, and cannabis carries distinct risks in this age group including cognitive effects, drug interactions, orthostatic hypotension, and falls. The heterogeneity of cannabis products, variable cannabinoid concentrations, and lack of standardized dosing further complicate the evidence base and make it difficult to counsel patients on safety and efficacy. Given these complexities, healthcare providers should proactively ask older patients about cannabis use during medication reconciliation, remain nonjudgmental about their symptom management choices, and where patients express interest, discuss both the limited evidence and known risks while documenting use in the medical record to 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/medical-illness/) Have thoughts on this? Share it: [X Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Older%20Adults%20Turn%20to%20Cannabis%20Primarily%20for%20Symptom%20Management%20-%20Pulmonology%20Advisor%20%40drcaplan&url=https%3A%2F%2Fcedclinic.com%2F%3Fp%3D56856)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2F%3Fp%3D56856)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Older%20Adults%20Turn%20to%20Cannabis%20Primarily%20for%20Symptom%20Management%20-%20Pulmonology%20Advisor%20via%20%40drcaplan.bsky.social%20https%3A%2F%2Fcedclinic.com%2F%3Fp%3D56856)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan)[📝 Read more on Substack](https://doctorapprovedcannabis.substack.com/)[🔔 Subscribe via RSS](https://cedclinic.com/feed/) Related Articles - [Older adults are using cannabis edibles, U of U study says – YouTube](https://cedclinic.com/older-adults-are-using-cannabis-edibles-based-on-word-of-mouth-recommendations/) - [Older adults are using cannabis edibles, U of U study says – ABC4 Utah](https://cedclinic.com/research-uncovers-motivations-behind-older-adults-use-of-cannabis-edibles/) - [Older Adults Turn to Cannabis Primarily for Symptom Management](https://cedclinic.com/older-adults-turn-to-cannabis-primarily-for-symptom-management/) 📰 Source: [https://www.pulmonologyadvisor.com/news/older-adults-turn-to-cannabis-primarily-for-symptom-management/](https://www.pulmonologyadvisor.com/news/older-adults-turn-to-cannabis-primarily-for-symptom-management/) Further Reading CED Clinic Blog[Why Cannabis Works](https://cedclinic.com/why-cannabis-works/) Evidence Watch[Cannabis and Heart Health](https://cedclinic.com/cannabis-cardiovascular-health-study/) CED Clinic Blog[Cannabis for Sleep](https://cedclinic.com/cannabis-for-sleep/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).